Table 2 Kruskal-Wallis test output from the analysis of synaptic markers vs. CDR scores.

From: Moderate decline in select synaptic markers in the prefrontal cortex (BA9) of patients with Alzheimer’s disease at various cognitive stages

Markers

p-value

VGLUT1

0.0001

VGLUT2

0.4154

EAAT2

0.1918

PSD95

0.0118

Somatostatin

0.0001

VIAAT

0.0056

ChAT

0.0150

Synaptophysin

0.0313

α-Tubulin

0.0183